About Hemera Biosciences
Hemera Biosciences is a company based in Medford (United States) founded in 2010. Hemera Biosciences has raised $3.75 million across 1 funding round. Hemera Biosciences operates in a competitive market with competitors including Insitro, BridgeBio, ATAI, Forge Biologics and Spark Therapeutics, among others.
- Headquarter Medford, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3.75 M (USD)
in 1 rounds
-
Latest Funding Round
$3.75 M (USD), Series A
Apr 01, 2013
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Hemera Biosciences
Hemera Biosciences has successfully raised a total of $3.75M through 1 strategic funding round. The most recent funding activity was a Series A round of $3.75 million completed in April 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Hemera Biosciences
Investment portfolio details for Hemera Biosciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Hemera Biosciences
Detailed financials for Hemera Biosciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Hemera Biosciences Comparisons
Peer comparison for Hemera Biosciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Hemera Biosciences
Hemera Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insitro, BridgeBio, ATAI, Forge Biologics and Spark Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| Locked | Locked | Locked |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| Locked | Locked | Locked |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| Locked | Locked | Locked |
Gene therapies for rare diseases are developed to treat patients.
|
|
| Locked | Locked | Locked |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| Locked | Locked | Locked |
Provider of cell therapies to treat cancer and hematologic conditions
|
Detailed competitors of Hemera Biosciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Hemera Biosciences
Complete news archive for Hemera Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hemera Biosciences
Hemera Biosciences was founded in 2010 and raised its 1st funding round 3 years after it was founded.
Hemera Biosciences is headquartered in Medford, United States. It is registered at Medford, Oregon, United States.
Hemera Biosciences is a funded company, having raised a total of $3.75M across 1 funding round to date.
Hemera Biosciences was founded in 2010 and is based in Medford, United States. Focus is placed on the biotechnology sector, where anti-complement gene-based therapies are developed for dry and wet age-related macular degeneration (AMD). This condition represents the primary cause of blindness in older adults, with no options available for 90 of dry AMD cases. Preclinical models have shown reductions in complement-mediated damage to eye tissues through proprietary recombinant molecules.
Hemera Biosciences's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.